Zealand Pharma A/s Stock
€42.03
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -0.900% | -6.853% | 6.826% | -23.170% | -33.714% | 22.360% | 76.121% |
| Saniona AB | -0.580% | -4.022% | -13.442% | 73.362% | -36.548% | 137.232% | -34.850% |
| Ocuphire Pharma Inc. | -2.260% | -3.571% | -5.677% | 406.448% | 156.837% | -22.995% | - |
| NanoViricides Inc. | -2.670% | 23.077% | 66.474% | 29.730% | 54.839% | 30.909% | -46.389% |
News
SAB Biotherapeutics Q1 Earnings Call Highlights
SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New

